✦ LIBER ✦

Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children

✍ Scribed by Olfat Ismael; Akira Shimada; Asahito Hama; Hiroshi Sakaguchi; Sayoko Doisaki; Hideki Muramatsu; Nao Yoshida; Masafumi Ito; Yoshiyuki Takahashi; Naohiro Akita; Shosuke Sunami; Yoshitoshi Ohtsuka; Youji Asada; Hiroyuki Fujisaki; Seiji Kojima

Book ID: 112167998
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 567 KB
Volume: 59
Category: Article
ISSN: 1545-5009
DOI: 10.1002/pbc.23409

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of polycythemia vera and esse

Prevalence of polycythemia vera and essential thrombocythemia

✍ Xiaomei Ma; Gary Vanasse; Brenda Cartmel; Yun Wang; H. Andrew Selinger 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Discriminating between essential thrombo

Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients

✍ Barbui, Tiziano; Thiele, Jürgen; Carobbio, Alessandra; Guglielmelli, Paola; Ramb 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

The risk of thrombosis in essential thro

The risk of thrombosis in essential thrombocythemia and polycythemia vera

✍ Thomas C. Pearson 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 78 KB

TET2 mutations and their clinical correl

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

✍ Tefferi, A; Pardanani, A; Lim, K-H; Abdel-Wahab, O; Lasho, T L; Patel, J; Gangat 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

Factor V Leiden mutation carriership and

Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia

✍ Marco Ruggeri; Heinz Gisslinger; Alberto Tosetto; Claudia Rintelen; Christine Ma 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract Polycythemia Vera (PV) and Essential Thrombocythemia (ET) are chronic myeloproliferative disorders complicated by a high incidence of thrombotic complications. Extensive coagulation studies failed to demonstrate a consistent pattern of abnormalities associated with thrombosis. Recently,

Interferon and the treatment of polycyth

Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis

✍ Silver, Richard T; Kiladjian, Jean-Jacques; Hasselbalch, Hans Carl 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 942 KB